Jeremy Foote

Associate Professor

The University of Alabama

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jeremy Foote is an Associate Professor at The University of Alabama at Birmingham, USA. His research focuses on cancer biology, particularly in the areas of renal cancer, gastrointestinal cancer, and pancreatic ductal adenocarcinoma. Recent publications include studies on the role of HDAC7 in cancer progression and novel mechanisms for enhancing chemotherapy efficacy.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (15)

Jennifer (Jey) Koehler

Professor

Auburn University

UNITED STATES

Jeremy Foote

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer

HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism

Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine

A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.

Iron Oxide Nanoparticles Inhibit Tumor Progression and Suppress Lung Metastases in Mouse Models of Breast Cancer

Breaking the stromal barrier in pancreatic cancer: Advances and challenges

Cutting Edge: Low-dose Recombinant IL-2 Treatment Prevents Autoantibody Responses in Systemic Lupus Erythematosus via Regulatory T Cell–independent Depletion of T Follicular Helper Cells

Microbiota and B-1 B cell repertoire development in mice.

Preclinical safety evaluation of continuous UV-A lighting in an operative setting

Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges.

A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts

Histopathology of pig kidney grafts with/without expression of the carbohydrate Neu5Gc in immunosuppressed baboons.

What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?

Evidence suggesting that deletion of expression of N-glycolylneuraminic acid (Neu5Gc) in the organ-source pig is associated with increased antibody-mediated rejection of kidney transplants in baboons.

Initial evidence that blockade of the CD40/CD154 costimulation pathway alone is sufficient as maintenance therapy in xenotransplantation

A perspective on the potential detrimental role of inflammation in pig orthotopic heart xenotransplantation

Immunological selection and monitoring of patients undergoing pig kidney transplantation

Stable expression of the human thrombomodulin transgene in pig endothelial cells is associated with a reduction in the inflammatory response.

Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.

Pig kidney xenotransplantation: Progress toward clinical trials.

Collaborators (15)

Jennifer (Jey) Koehler

Adam Keeton

Zheng-Yu Wang

Han-Fei Ding

Kevin Benner

Robert Ivkov

Frances E. Lund

Darshan Shimoga Chandrashekar

Ganji Purnachandra Nagaraju

Sooryanarayana Varambally

Julienne Carstens

Mohamed Ezzelarab

Carmen De Miguel

R. Glenn King

Takayuki Yamamoto

Make your next move.